Intuitive Surgical reports Q1 adjusted EPS $2.50, consensus $2.11

Reports Q1 revenue $2.77B, consensus $2.62B. Worldwide procedures (da Vinci and Ion combined) grew approximately 17% compared with the first quarter of 2025. Da Vinci procedures grew approximately 16%, and Ion procedures grew approximately 39%. The Company placed 431 da Vinci surgical systems, compared with 367 in the first quarter of 2025. The first quarter 2026 da Vinci surgical system placements included 232 da Vinci 5 systems, compared with 147 in the first quarter of 2025. The Company placed 52 Ion endoluminal systems, compared with 49 in the first quarter of 2025.